Determination of the effect of sedative of Dexmedetomidine and Fentanyl with Propofol and Fentanyl in participants undergoing colonoscopy

The comparison of the effect of sedative of Dexmedetomidine and Fentanyl with Propofol and Fentanyl in participants undergoing colonoscopy

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170805035510N4

Enrollment

Registered

2019-05-22

Start date

2018-05-23

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Participants candidates for colonoscopy for diagnosis any disease.

Interventions

Intervention 1: Intervention group: Combination of Propofol and Fentanyl, Once before colonoscopy the dosage was injectable ketamine Propofol 500 mg/ml) and fentanyl (fentanyl 1 µg/kg). Propofol, as D

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA Class I, II

Exclusion criteria

Exclusion criteria: Patients with complete heart block Liver failure Severe heart failure

Design outcomes

Primary

Measure	Time frame
Sedation. Timepoint: After colonoscopy. Method of measurement: Visual Analogue Scale (VAS).	—

Secondary

Measure	Time frame
Pain. Timepoint: After colonoscopy. Method of measurement: Visual Analogue Scale (VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPejman Pourfakhr

Tehran University of Medical Sciences

pourfakhr@tums.ac.ir+98 21 8863 5770

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026